Boston Operating Income from 2010 to 2024

BSX Stock

USD 74.17 0.38 0.51%

Boston Scientific Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Boston Scientific Corp generates from its operations. View All Fundamentals

Operating Income

First Reported

1991-03-31

Previous Quarter

584 M

Current Value

693 M

Quarterly Volatility

592.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 193.9 M or Selling General Administrative of 5.2 B, as well as many exotic indicators such as Price To Sales Ratio of 4.58, Dividend Yield of 3.0E-4 or PTB Ratio of 5.87. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.

This module can also supplement Boston Scientific's financial leverage analysis and stock options assessment as well as various Boston Scientific Technical models . Check out the analysis of Boston Scientific Correlation against competitors.

Latest Boston Scientific's Operating Income Growth Pattern

Below is the plot of the Operating Income of Boston Scientific Corp over the last few years. Operating Income is the amount of profit realized from Boston Scientific Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Boston Scientific Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Boston Scientific's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Boston Operating Income Regression Statistics

	Arithmetic Mean	766,243,333
	Geometric Mean	842,878,545
	Coefficient Of Variation	200.78
	Mean Deviation	1,047,461,333
	Median	1,044,000,000
	Standard Deviation	1,538,454,108
	Sample Variance	2366841T
	Range	6.3B
	R-Value	0.70
	Mean Square Error	1292639.5T
	R-Squared	0.49
	Significance	0
	Slope	241,509,107
	Total Sum of Squares	33135774.6T

Boston Operating Income History

	2024	2.5 B
	2023	2.3 B
	2022	1.6 B
	2021	2 B
	2020	1 B
	2019	1.5 B
	2018	1.5 B

Other Fundumenentals of Boston Scientific Corp

Non Operating Income Net Other

Boston Scientific Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.94	0.5	0.89	0.94	0.77	0.83	0.1	0.59	0.78	0.66	0.87	0.9	-0.75	0.83	-0.45	0.77	0.69	0.79	-0.59	0.66	-0.03	0.66	0.87	0.8	0.7
Total Stockholder Equity	0.97		0.87	0.65	0.9	0.88	0.65	0.78	0.01	0.43	0.77	0.53	0.82	0.89	-0.65	0.81	-0.37	0.85	0.74	0.83	-0.49	0.6	-0.1	0.7	0.91	0.84	0.78
Net Debt	0.94	0.87		0.41	0.83	0.93	0.82	0.79	0.32	0.64	0.84	0.65	0.87	0.82	-0.78	0.77	-0.55	0.64	0.69	0.69	-0.66	0.74	0.17	0.51	0.82	0.71	0.56
Retained Earnings	0.5	0.65	0.41		0.59	0.3	0.05	0.3	-0.13	-0.31	0.57	-0.23	0.4	0.46	-0.12	0.4	-0.18	0.71	0.78	0.66	-0.07	0.36	-0.16	0.6	0.79	0.72	0.69
Accounts Payable	0.89	0.9	0.83	0.59		0.89	0.58	0.7	0.12	0.3	0.85	0.52	0.72	0.79	-0.74	0.78	-0.52	0.82	0.69	0.85	-0.67	0.58	-0.02	0.64	0.86	0.77	0.8
Net Receivables	0.94	0.88	0.93	0.3	0.89		0.76	0.73	0.27	0.67	0.77	0.75	0.76	0.83	-0.76	0.8	-0.46	0.67	0.52	0.7	-0.7	0.57	0.14	0.43	0.73	0.6	0.64
Total Liab	0.77	0.65	0.82	0.05	0.58	0.76		0.92	0.25	0.84	0.59	0.85	0.9	0.83	-0.78	0.82	-0.56	0.35	0.55	0.58	-0.58	0.62	0.09	0.48	0.6	0.58	0.29
Total Current Assets	0.83	0.78	0.79	0.3	0.7	0.73	0.92		0.1	0.62	0.68	0.75	0.93	0.89	-0.82	0.89	-0.54	0.59	0.72	0.8	-0.58	0.71	-0.06	0.75	0.77	0.81	0.53
Short Term Debt	0.1	0.01	0.32	-0.13	0.12	0.27	0.25	0.1		0.28	0.51	0.13	-0.01	0.08	-0.17	0.09	-0.23	-0.18	-0.11	-0.03	-0.28	0.22	0.97	-0.24	0.02	-0.12	-0.1
Intangible Assets	0.59	0.43	0.64	-0.31	0.3	0.67	0.84	0.62	0.28		0.27	0.86	0.61	0.61	-0.52	0.55	-0.29	0.05	0.1	0.18	-0.38	0.3	0.19	0.07	0.22	0.16	0.01
Short Term Investments	0.78	0.77	0.84	0.57	0.85	0.77	0.59	0.68	0.51	0.27		0.37	0.66	0.68	-0.68	0.66	-0.62	0.66	0.67	0.73	-0.66	0.77	0.38	0.58	0.81	0.74	0.61
Common Stock	0.66	0.53	0.65	-0.23	0.52	0.75	0.85	0.75	0.13	0.86	0.37		0.68	0.7	-0.73	0.72	-0.45	0.3	0.25	0.47	-0.63	0.42	-0.02	0.28	0.34	0.33	0.3
Long Term Debt	0.87	0.82	0.87	0.4	0.72	0.76	0.9	0.93	-0.01	0.61	0.66	0.68		0.88	-0.79	0.85	-0.58	0.61	0.83	0.76	-0.57	0.73	-0.17	0.72	0.84	0.83	0.51
Good Will	0.9	0.89	0.82	0.46	0.79	0.83	0.83	0.89	0.08	0.61	0.68	0.7	0.88		-0.64	0.95	-0.42	0.66	0.72	0.82	-0.47	0.54	-0.04	0.63	0.81	0.75	0.64
Treasury Stock	-0.75	-0.65	-0.78	-0.12	-0.74	-0.76	-0.78	-0.82	-0.17	-0.52	-0.68	-0.73	-0.79	-0.64		-0.69	0.58	-0.55	-0.54	-0.66	0.84	-0.72	0.03	-0.61	-0.65	-0.68	-0.45
Property Plant Equipment	0.83	0.81	0.77	0.4	0.78	0.8	0.82	0.89	0.09	0.55	0.66	0.72	0.85	0.95	-0.69		-0.45	0.68	0.72	0.87	-0.54	0.5	-0.04	0.56	0.79	0.72	0.68
Current Deferred Revenue	-0.45	-0.37	-0.55	-0.18	-0.52	-0.46	-0.56	-0.54	-0.23	-0.29	-0.62	-0.45	-0.58	-0.42	0.58	-0.45		-0.27	-0.48	-0.4	0.71	-0.64	-0.11	-0.41	-0.47	-0.49	-0.17
Net Tangible Assets	0.77	0.85	0.64	0.71	0.82	0.67	0.35	0.59	-0.18	0.05	0.66	0.3	0.61	0.66	-0.55	0.68	-0.27		0.71	0.85	-0.45	0.57	-0.27	0.65	0.83	0.82	0.87
Long Term Debt Total	0.69	0.74	0.69	0.78	0.69	0.52	0.55	0.72	-0.11	0.1	0.67	0.25	0.83	0.72	-0.54	0.72	-0.48	0.71		0.85	-0.38	0.68	-0.24	0.76	0.92	0.89	0.68
Capital Surpluse	0.79	0.83	0.69	0.66	0.85	0.7	0.58	0.8	-0.03	0.18	0.73	0.47	0.76	0.82	-0.66	0.87	-0.4	0.85	0.85		-0.54	0.59	-0.16	0.76	0.89	0.86	0.91
Deferred Long Term Liab	-0.59	-0.49	-0.66	-0.07	-0.67	-0.7	-0.58	-0.58	-0.28	-0.38	-0.66	-0.63	-0.57	-0.47	0.84	-0.54	0.71	-0.45	-0.38	-0.54		-0.62	-0.13	-0.37	-0.49	-0.46	-0.41
Long Term Investments	0.66	0.6	0.74	0.36	0.58	0.57	0.62	0.71	0.22	0.3	0.77	0.42	0.73	0.54	-0.72	0.5	-0.64	0.57	0.68	0.59	-0.62		0.06	0.65	0.67	0.75	0.41
Short Long Term Debt	-0.03	-0.1	0.17	-0.16	-0.02	0.14	0.09	-0.06	0.97	0.19	0.38	-0.02	-0.17	-0.04	0.03	-0.04	-0.11	-0.27	-0.24	-0.16	-0.13	0.06		-0.36	-0.1	-0.25	-0.18
Cash And Equivalents	0.66	0.7	0.51	0.6	0.64	0.43	0.48	0.75	-0.24	0.07	0.58	0.28	0.72	0.63	-0.61	0.56	-0.41	0.65	0.76	0.76	-0.37	0.65	-0.36		0.78	0.92	0.6
Net Invested Capital	0.87	0.91	0.82	0.79	0.86	0.73	0.6	0.77	0.02	0.22	0.81	0.34	0.84	0.81	-0.65	0.79	-0.47	0.83	0.92	0.89	-0.49	0.67	-0.1	0.78		0.94	0.77
Net Working Capital	0.8	0.84	0.71	0.72	0.77	0.6	0.58	0.81	-0.12	0.16	0.74	0.33	0.83	0.75	-0.68	0.72	-0.49	0.82	0.89	0.86	-0.46	0.75	-0.25	0.92	0.94		0.69
Capital Stock	0.7	0.78	0.56	0.69	0.8	0.64	0.29	0.53	-0.1	0.01	0.61	0.3	0.51	0.64	-0.45	0.68	-0.17	0.87	0.68	0.91	-0.41	0.41	-0.18	0.6	0.77	0.69

Click cells to compare fundamentals

About Boston Scientific Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Boston Scientific income statement, its balance sheet, and the statement of cash flows. Boston Scientific investors use historical funamental indicators, such as Boston Scientific's Operating Income, to determine how well the company is positioned to perform in the future. Although Boston Scientific investors may use each financial statement separately, they are all related. The changes in Boston Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Boston Scientific's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Boston Scientific Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	2.3 B	2.5 B
Non Operating Income Net Other	-43.7 M	-41.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Boston Scientific Correlation against competitors.

You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.579

Earnings Share

1.19

Revenue Per Share

10.065

Quarterly Revenue Growth

0.138

Return On Assets

0.0454

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Operating Income from 2010 to 2024

Latest Boston Scientific's Operating Income Growth Pattern

Boston Operating Income Regression Statistics

Boston Operating Income History

Other Fundumenentals of Boston Scientific Corp

Boston Scientific Operating Income component correlations

About Boston Scientific Financial Statements

Also Currently Popular

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY